CCRN241220P22500
- 0.00
- 0.000.00%
Cross Country Healthcare Newsroom
Jefferies Initiates Cross Country Healthcare(CCRN.US) With Hold Rating, Announces Target Price $12
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Cuts Target Price to $14
Cross Country Healthcare Is Maintained at Buy by Benchmark
Cross Country Healthcare Analyst Ratings
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cross Country Healthcare (CCRN), CVS Health (CVS) and Privia Health Group (PRVA)
Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Cuts Target Price to $18
JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
JMP Securities Sticks to Their Hold Rating for Cross Country Healthcare (CCRN)
Cross Country Healthcare Analyst Ratings
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Announces Target Price $15
Barrington Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19
Buy Rating Affirmed for Cross Country Healthcare Amidst Growth and Strategic Optimism
Cross Country Healthcare Analyst Ratings
Buy Rating Affirmed for Cross Country Healthcare Amidst Resilient Q2 Performance and Strategic Growth Potential
Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $17
Cross Country Healthcare Analyst Ratings
Oppenheimer Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19
Cross Country Healthcare (CCRN) Receives a Rating Update From a Top Analyst